`Case 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 1 of 12 PageID #: 1137
`Cas
`
`“sDBDWn&Wwbw
`
`oo
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`)Case No.: 22-ev-00252-MSG
`ARBUTUS BIOPHARMA
`CORPORATION AND GENEVANT_)
`SCIENCES GMBH,
`)
`Plaintiffs,)
`)
`)
`)
`
`NOTICE OF MOTION AND
`MOTION FOR CLASS
`CERTIFICATION
`PROPOSED CLASS ACTION
`
`Vv.
`MODERNA,INC. and MODERNATX,
`
`)
`Defendants.)
`
`) )
`
`INC.
`
` )
`EMANUEL MCCRAY,On Behalfof
`Himselfand All Others Similarly Situated, )
`)
`Intervenors-Plaintiffs.)
`)
`ao)
`
`To Plaintiffs Arbutus Biopharma Corporation and Genevant Sciences GmbH
`
`and their attorneys of record, to Defendants Moderna, Inc. and ModernaTx,Inc. and
`
`their attorneys of record, and to the United States and its attorneys of record,
`
`PLEASE TAKE NOTICEthat on 2023, at _
`
`in the Courtroom
`
`
`
`Cas 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 2 of 12 PagelD #: 1138
`Case 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 2 of 12 PageID #: 1138
`
`of the presiding judge in this case in the Federal Courthouse in Fort Worth, Texas,
`
`or as soon thereafter as Plaintiffs-Intervenors may be heard, Plaintiffs-Intervenors
`
`will and do hereby movethe Court for an order certifying this case as a class action
`
`pursuant to Rule 23(a) and (b) of the Federal Rules of Civil Procedure on behalf of
`
`the following class of similarly situated persons:
`
`All persons born or naturalized in the United States whoare citizens of
`the United States, and subject to the jurisdiction of the United States.
`
`This motion is based upon the accompanying memorandum oflaw and upon
`
`all other matters of record herein. In accordance with Local Rule 7.1.1, a
`
`conference was not. Thelast action on the Docket occurred on February 22, 2023,
`
`(Doc. 55), granting Motion for Pro Hac Vice Appearance of Attorney Nancy Kaye
`
`Horstman.
`
`Dated: February 26, 2023
`
`Respectfully submitted,
`
`Emanuel McCray
`
`G
`
`2700 Caples Street
`P.O. Box 3134
`Vancouver, WA 98668
`(564) 208-7576
`emanuel.mccray@hotmail.com
`
`
`
`Casd|1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 3 of 12 PagelD #: 1139
`Case 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 3 of 12 PageID #: 1139
`
`TABLE OF CONTENTS
`
`TABLE OF CONTENTS........ ccc cssssssssssscssssssecesssessesssseeseecsecesensasenseesasatenseeseaneeneeneenees i
`
`TABLE OF AUTHORITIES. 0... cccccsscstssssssenssssssesssssssscsssnssesssaseessessnsssssessessnsensens il
`
`INTRODUCTION 00... eececscesssesescssessecsssosessnsecssseesenssseasscsssscntessnesseensseeaseaasenseeuenaene 1
`
`ARGUMENT
`
`I.
`
`THE PROPOSED CLASS MEETSRULE23000... ccccccssscsseseeseseeveneeee ]
`
`—
`
`OocoNDBWTF&FWWN
`
`19.||CONCLUSION....ccecssssssscssssssessssssccccsesssssssssesseceusussssssecsessunussssseeeeessnasassseeseensnnnens5
`
`
`
`Cas 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 4 of 12 PagelD #: 1140
`Case 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 4 of 12 PageID #: 1140
`
`TABLE OF AUTHORITIES
`
`Cases
`
`Page(s)
`
`Bondv. U.S.
`564 U.S. 211, 222 (2011) oreeeeeesesseeseesseessesssssseessessnsssnessenseneesreaseaeennes ores 1,5
`
`Califano v. Yamasaki
`442 U.S. 682, 700-701 (1979) vee ecssesssesscccsecesscsecssctevsessessesssesnsveesseeseses ene 1,2
`
`Gen. Tel. Co. of Sw.v. Falcon
`457 U.S. 147, 155, 161 (1982) oes cseeccseneesesessesessssssessesesenssssereeteeee oe 2
`
`In re Hydrogen Peroxide AntitrustLitig.
`552 F.3d 305, 309-310 (3d Cir. 2008) oc escsscsscssenscesssrscessenssseseesenee os2,4
`
`Lanner v. Wimmer
`662 F.2d 1349, 1357 (LOth Cir. 1981) oo.ee scssesseecnecnecessrscescesersetseetee fees 5
`
`Leisner v. New York Telephone Co.
`358 F. Supp. 359, 372 (S.D.N.Y. 1973) ...eeccescssssssscsccesssseessorsescssctssseseeses fees5
`
`Rice v. City of Philadelphia
`66 F.R.D. 17, 20 (E.D. Pa. 1974) vo escessesecceeseescseeseseeessesrsseessesnsassnee sees2
`
`United States Fidelity Guaranty Co. v. Lord
`585 F.2d 860, 873 (8th Cir. 1978) ....eesscsescsscssscssecsscrsersessesstsssnsnsase eens5
`
`Statutes
`
`Federal Rules of Civil Procedure
`
`Rule 23 .....sscccsssssscsrsescecssesseessevetsessesssessesnessceesscnsecsecesaceasesasensseeteenenseesseses seen nea3
`Rule 23(a) ....cceccccsssssssscesscsscessecesscessesscsessecsacesceaccaccsessncesceessqsceseneessoses enesee eas5
`Rule 23(a)(1) ......cesccsescssssecsccessctsssscnesscsesccssosessosecesseseesesoescsesseesseesesnsren se ree ees3
`Rule 23(a)(3) .....cscsssssscsccsccseccsssessssceccsacsscseseosercessesceectsosesesseseseaseessess se eeeeen3,4
`Rule 23(b)(3) c..cccsssscesssscssssessssssscessessesessensscessesetseseaesusersesenessenscacseearses +Sv eseeaes6
`
`
`
`Casd[1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 5 of 12 PagelD #: 1141
`Case 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 5 of 12 PageID #: 1141
`
`wm&Wwbh
`moCOSsDH
`
`MEMORANDUM OF POINTS AND AUTHORITIES
`IN SUPPORT OF MOTION FOR CLASS CERTIFICATION
`
`THE PROPOSED CLASS MEETSRULE23.
`
`A.
`
`General.
`
`The proposed Complaint is incorporated herein as if repeated here.
`
`In Bond v. U.S., 564 U.S. 211, 222 (2011), the Supreme Court statedthat:
`
`“Fidelity to principles of federalism is not for the States alone to
`vindicate. The recognition of an injured person’s standing to object to a
`violation of a constitutional principle that allocates power within
`governmentis illustrated, in an analogous context, by cases in which
`individuals sustain discrete, justiciable injury from actionsthat
`transgress separation-of-powers limitations. Separation-of-powers
`principles are intended,in part, to protect each branch of government
`from incursion by the others. Yet the dynamic between and amongthe
`branchesis not the only object of the Constitution’s concern. The
`structural principles secured by the separation of powers protect the
`individual as well.”
`
`In Califano v. Yamasaki, 442 U.S. 682, 700-701 (1979), the Supreme Court
`
`held that:
`
`“[C]lass relief is appropriate in civil actions brought in federal court,
`including those seeking to overturn determinations of the departments
`of the Executive Branch of the Government in cases where judicial
`review of such determinationsis authorized.... Indeed, a wide variety
`of federal jurisdictional provisions speak in terms of individual
`plaintiffs, but class relief has never been thought to be unavailable
`under them. (Citations omitted.) Where the district court has
`jurisdiction over the claim of each individual memberofthe class, Rule
`23 provides a procedure by which the court may exercise that
`jurisdiction over the various individual claimsin a single proceeding.”
`
`
`
`1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 6 of 12 PagelD #: 1142
`Cas
`Case 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 6 of 12 PageID #: 1142
`
`A class action may be established if (1) the class is so numerousthat joinder
`
`of all members is impracticable, (2) there are commonquestionsof law orfact
`
`concerningtheclass, (3) the claims or defenses of the representative parties are
`
`typical of the claims or defenses of the class, and (4) the interests of the class will
`
`be fairly and adequately protected by the representative parties. In re Hydrogen
`
`Peroxide Antitrust Litig., 552 F.3d 305, 309-310 (3d Cir. 2008), citing Gen. Tel. Co.
`
`ofSw. v. Falcon, 457 U.S. 147, 155, 161 (quoting Califano v. Yamasaki, 442 U.S.
`
`— &W
`
`wWN
`Ooco8NNDHWN
`
`682, 700-01 (1979)).
`
`“Thetrial court, well-positioned to decide which facts and legal arguments
`
`are most important to each Rule 23 requirement, possesses broad discretion to
`
`control proceedings and frame issues for consideration under Rule 23.” Jd. 552 F.3d
`
`at 310.
`
`“Defining a class as consisting of all persons who have been or will be
`
`affected by the conduct charged to the defendants is entirely appropriate where only
`
`injunctive or declaratory relief is sought.” Rice v. City ofPhiladelphia, 66 F.R.D.
`
`17, 20 (E.D. Pa. 1974).
`
`The proposedclass is clear and is defined by whether Modernaand the
`
`United States may constitutionally shift Moderna’s liabilities for its COVID-19
`
`“prototype pathogen”vaccines to the United States in violation of the principles of
`
`federalism and the separation of powers doctrine.
`
`
`
`Cas4j 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 7 of 12 PagelD #: 1143
`Case 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 7 of 12 PageID #: 1143
`
`oOocoNJBDwrF&FWWHO—
`fhammammcmmmtDRAF&FWwWHNO—|—&
`
`17
`
`Moreover, the existing parties cannot adequately protect the “powers”
`
`reserved to the People of the United States in the Tenth Amendment withouttheir
`
`assistance.
`
`B.
`
`Numerosity and Impracticality of Joinder
`
`The proposedclass satisfies Rule 23(a)(1) becausethe class size is
`
`approximately 334,000,000 individuals andis “so numerousthat joinderis
`
`impractical.” Thus, the proposedclass plainly satisfies the numerosity requirement
`
`of Rule 23(a).
`
`C.
`
`Common Questions of Law or Fact
`
`All putative class members have the samerights guaranteed under the Federal
`
`Constitution and certain “powers” reserved to them under the Tenth Amendment. A
`
`sole discreet legal question all putative Plaintiffs-Intervenors share in common with
`
`the existing Plaintiffs is may constitutionally shift Moderna’s liabilities forits
`
`COVID-19 “prototype pathogen” vaccines to the United States in violation of the
`
`principles of federalism and the separation of powers doctrine.
`
`D.
`
` Typicality of Claims.
`
`Rule 23(a)(3) requires that the claims be “typical of the claims... of the
`
`class.” The loss of constitutional sovereignty and powers reserved to the People of
`
`the United States is typical of the putative class. Because McCrayis a citizen of the
`
`United States and is amongthe “people” to whom the Tenth Amendmentreserves
`
`
`
`Casq|1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 8 of 12 PagelD #: 1144
`Case 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 8 of 12 PageID #: 1144
`
`aIDnOAFSFWDNHN
`
`oo
`
`“powers not delegated to the United States by the Constitution, nor prohibited byit
`
`to the States”, McCray has Article III standing to pursue declaratory relief under the
`
`typicality requirements of Rule 23 and this Court has already pointed to the
`
`difficulties Moderna and the United States face in their efforts to shift Moderna’s
`
`liabilities to the United States.
`
`Certification under Rule 23(b)(3), which is permissible when the court “finds
`
`that the questions of law or fact common to class members predominate over any
`
`questions affecting only individual members, and that a class action is superior to
`
`other available methodsforfairly and efficiently adjudicating the controversy.”
`
`(Citation omitted.) The twin requirements of Rule 23(b)(3) are known as
`
`predominance andsuperiority. In re Hydrogen Peroxide Antitrust Litig., 552 F.3d at
`
`310.
`
`“Predominance ‘tests whether proposed classes are sufficiently cohesive to
`
`warrant adjudication by representation.... Issues commonto the class must
`
`predominate.... [A] district court must formulate some prediction as to how specific
`
`issues will play out in order to determine whether commonorindividual issues
`
`predominate in a given case....” Id. 552 F.3d at 310-11.
`
`In this case, McCray and the proposed class members’ legal and remedial
`
`theories predominate and are exactly the same. The predominance,superiority and
`
`typicality requirement of Rule 23(a)(3) are therefore satisfied.
`
`
`
`Cas@| 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 9 of 12 PagelD #: 1145
`Case 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 9 of 12 PageID #: 1145
`
`“aDOWFSeWYbb
`
`oo
`
`E.
`
`Adequacy of Representation.
`
`The final requirementfor class certification, set out in Rule 23(a)(4), is that
`
`the namedplaintiffs “will fairly and adequately protect the interest of the class.”
`
`McCrayis a citizen of the United States. The Federal Constitution applies
`
`equally to each citizen of the United States. See Bond, 564 U.S. at 222 (2011):
`
`“Fidelity to principles of federalism is not for the States alone to vindicate.... The
`
`structural principles secured by the separation of powers protect the individual as
`
`well.” There are no formalor personal conflicts of interests between McCray,the
`
`putative class members, and the single claim for declaratory relief which McCray
`
`seeks to pursue.
`
`Moreover,“[i]t is not ‘fatal if some membersof the class might prefer not to
`
`have violations of their rights remedied.’” Lanner v. Wimmer, 662 F.2d 1349, 1357
`
`(10th Cir. 1981), citing United States Fidelity Guaranty Co. v. Lord,585 F.2d 860,
`
`873 (8th Cir. 1978) (quoting Leisner v. New York Telephone Co.,358 F. Supp. 359,
`
`372 (S.D.N.Y. 1973)), cert. denied, 440 U.S. 913, 99 S.Ct. 1228, 59 L.Ed.2d 462
`
`(1979). Whether McCray will adequately represent the class is a question offact to
`
`be ‘raised and resolved in the trial court in the usual manner.
`
`Il.
`
`CONCLUSION
`
`For the foregoing reasons, this action for declaratory relief should be certified
`
`as a class action pursuant to Fed.R.Civ.Proc., Rule 23(a) and (b).
`
`5
`
`
`
`Case][1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 10 of 12 PagelD #: 1146
`Case 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 10 of 12 PageID #: 1146
`
`Respectfully submitted this 26" day of February
`2023.
`
`CimancalWhe
`Emanuel McCray
`2700 Caples Street
`P.O. Box 3134
`Vancouver, WA 98668
`(564) 208-7576
`emanuel.mccray@hotmail.com
`
`—
`
`-_WwWN
`moOoNNBDNM
`
`
`
`Case[[:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 11 of 12 PagelD #: 1147
`Case 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 11 of 12 PageID #: 1147
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`— 2 3 4 5 6 7
`
`8
`
`9
`
`)Case No.: 22-cv-00252-MSG
`ARBUTUS BIOPHARMA
`
`11||CORPORATION AND GENEVANT _)
`
`12||SCIENCES GMBH, )
`Plaintiffs)©CERTIFICATE OF SERVICE
`13
`)
`14
`
`10
`
`V.
`
`))
`
`!5||MODERNA,INC. and MODERNATX, _)
`
`
`16||INC. )
`Defendants.)
`)
`17
`)
`18
`EMANUEL MCCRAY,On Behalfof—)
`19||Himselfand All Others Similarly Situated, )
`20
`)
`1
`Intervenors-Plaintiffs.)
`)
`22 ee
`
`I hereby certify that on the 26" day of February 2023, I mailed a copy ofthe
`
`26
`
`27
`
`following documents,
`
`(1) MOTION TO INTERVENE
`
`(2) CLASS ACTION COMPLAINT FOR DECLARATORY RELIEF
`
`1
`
`
`
`Case|fl:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 12 of 12 PagelD #: 1148
`Case 1:22-cv-00252-MSG Document 60-2 Filed 03/02/23 Page 12 of 12 PageID #: 1148
`
`(3) NOTICE OF MOTION AND MOTION FOR CLASS CERTIFICATION,
`
`with postage prepaid, to all parties addressed as follows:
`
`Attorneysfor the United States
`
`MICHAEL GRANSTON
`GARYL. HAUSKEN
`PHILIP CHARLES STERNHELL
`HAYLEY A. DUNN
`KAVYASRI NAGUMOTU
`Commercial Litigation Branch
`Civil Division
`U.S. Departmentof Justice
`950 Pennsylvania Avenue, NW
`Washington, DC 20530-0001
`Email: Gary.L.Hausken@usdoj.gov
`Email: Philip.C.Sternhell@usdoj.gov
`Email: Hayley.A.Dunn@usdoj.gov
`Email: Kavyasri.Nagumotu@usdoj.gov
`
`DAVID C. WEISS
`United States Attorney
`1313 North MarketStreet
`PO Box 2046
`Wilmington, DE 19801
`Attorneyfor the United States
`
`JOHN W. SHAW
`NATHAN ROGER HOESCHEN
`KAREN ELIZABETH KELLER
`Shaw Keller LLP
`I.M.Pei Building
`1105 North Market Street
`12th Floor
`Wilmington, DE 19801
`Email: jshaw@shawkeller.com
`Email: nhoeschen@shawkeller.com
`Email: kkeller@shawkeller.com
`Attorneysfor Plaintiffs
`
`BRIAN P. EGAN
`JACK B. BLUMENFELD
`Morris, Nichols, Arsht & Tunnel! LLP
`1201 North Market Street
`P.O. Box 1347
`Wilmington, DE 19899
`302-351-9454
`Email: began@mnat.com
`Email: Jbbefiling@mnat.com
`Attorneysfor Defendants
`
`Emanuel McCray
`
`y
`
`—o
`
`O©IFDBvA&WwWWN
`
`